Skip to main content

Advertisement

SpringerLink
Log in

Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer

  • Clinical trial
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

The sentinel lymph node (SLN) is the only focus of axillary metastasis in a significant proportion of patients. In this single institutional study, clinicopathologic characteristics were investigated to determine the factors predicting the status of a SLN biopsy and the metastatic involvement of non-SLNs. Data were retrospectively reveiwed for 400 consecutive patients with clinical T1/T2 N0 breast cancer who underwent a SLN biopsy including axillary and/or internal mammary lymph nodes. The SLNs were evaluated by using the new AJCC staging criteria following multiple sectioning and immunohistochemical (IHC) analyses of nodes. The SLN contained metastases in 148 patients (38.5%) including 18 patients (12.2%) with micrometastases (≤0.2 mm) and 130 patients (87.8%) with macrometastases (>0.2 cm). Five patients had isolated tumor cells detected by IHC (≤0.2 mm, N0i). Patients with tumor size more than 2 cm (T1, 29.8% versus T2, 51.6%; OR=2.31, 95% CI, 1.50–3.56) and lymphovascular invasion (LVI-, 30.3% versus LVI+, 51.3%; OR=2.07, 95% CI, 1.34–3.19) were more likely to have positive SLNs in both univariate and multivariate analyses. Among patients with a positive SLN biopsy, those with T2 tumors (versus T1; 63.1% versus 36.9; OR=2.93, 95% CI, 1.43–6.04), macrometastases in SLNs (versus micrometastases; 88.9% versus 11.1%; OR=8.83; 95% CI, 1.82–42.87) and extracapsular node extension (versus without extracapsular node extension; 65.4% versus 34.6%; OR, 2.23; 95% CI, 1.05–4.72) were more likely to have non-SLN metastases in both univariate and multivarite analyses. These results indicate that clinicopathologic factors might be helpful to select patients who were less likely to have negative SLN or non-SLNs. However, additional factors are still needed to be identified to omit surgical axillary staging.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fisher ER, Anderson S, Redmond C, Fisher B, Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06: 10-year pathologic and clinical prognostic discriminants Cancer 1993. 71:2507–2514

    Article  PubMed  CAS  Google Scholar 

  2. Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP, Management and survival of female breast cancer: results of a national survey by the American College of Surgeons Cancer 1980. 45:2917–2924

    Article  PubMed  CAS  Google Scholar 

  3. Galea MH, Blamey RW, Elston CW, Ellis IO, The Nottingham Prognostic Index in primary breast cancer Breast Cancer Res Treat. 1992. 22:207–219

    Article  PubMed  CAS  Google Scholar 

  4. Kollias J, Murphy CA, Elston CW, Ellis IO, Robertson JF, Blamey RW, The prognosis of small primary breast cancers Eur J Cancer 1999. 35:908–912

    Article  PubMed  CAS  Google Scholar 

  5. Ozmen V, Muslumanoglu M, Cabioglu N, et al. Increased false negative rates in sentinel lymph node biopsies in patients with multi-focal breast cancer Breast Cancer Res Treat 2002. 76:237–244

    Article  PubMed  CAS  Google Scholar 

  6. Noguchi M, Current controversies concerning sentinel lymph node biopsy for breast cancer Breast Cancer Res Treat 2004. 84:261–271

    Article  PubMed  Google Scholar 

  7. Giuliano AE, Jones RC, Brennan M, Statman R, Sentinel lymphadenectomy in breast cancer J Clin Oncol 1997. 15:2345–2350

    PubMed  CAS  Google Scholar 

  8. Schrenk P, Shamiyeh A, Wayand W, Sentinel lymph-node biopsy compared to axillary lymph-node dissection for axillary staging in breast cancer patients Eur J Surg Oncol 2001. 27:378–382

    Article  PubMed  CAS  Google Scholar 

  9. Giuliano AE, Kirgan DM, Guenther JM, Morton DL, Lymphatic mapping and sentinel lymphadenectomy for breast cancer Ann Surg 1994. 220:391–401

    Article  PubMed  CAS  Google Scholar 

  10. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P, The sentinel node in breast cancer: a multicenter validation study N Engl J Med 1998. 339:941–946

    Article  PubMed  CAS  Google Scholar 

  11. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer JAMA 1996. 276:1818–1822

    Article  PubMed  CAS  Google Scholar 

  12. Czerniecki BJ, Scheff AM, Callans LS, et al. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel node biopsy in patients with breast cancer Cancer 1999. 85:1098–1103

    Article  PubMed  CAS  Google Scholar 

  13. Barnwell JM, Arredondo MA, Kollmorgen D, et al. Sentinel node biopsy in breast cancer Ann Surg Oncol 1998. 5:126–130

    Article  PubMed  CAS  Google Scholar 

  14. Galimberti V, Zurrida S, Zucali P, et al. Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients? The Breast 1998. 7:8–10

    Article  Google Scholar 

  15. Chu KU, Turner RR, Hansen NM, Brennan MB, Giuliano AE, Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis Ann Surg Oncol 1999. 6:756–761

    Article  PubMed  CAS  Google Scholar 

  16. Liang WC, Sickle-Santanello BJ, Nims TA, Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node? Am J Surg 2001. 182:365–368

    Article  PubMed  CAS  Google Scholar 

  17. van Iterson V, Leidenius M, Krogerus L, von Smitten K, Predictive factors for the status of non-sentinel nodes in breast cancer patients with tumor positive sentinel nodes Breast Cancer Res Treat 2003. 82:39–45

    Article  PubMed  Google Scholar 

  18. Reitsamer R, Peintinger F, Prokop E, Rettenbacher L, Menzel C, 200 Sentinel lymph node biopsies without axillary lymph node dissection -no axillary recurrences after a 3-year follow-up Br J Cancer 2004. 90:1551–1554

    Article  PubMed  CAS  Google Scholar 

  19. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 2003. 349:546–553

    Article  PubMed  Google Scholar 

  20. Ross MI, Sentinel node dissection in early-stage breast cancer: Ongoing prospective randomized trials in the USA Ann Surg Oncol 2001. 8:77–81

    Google Scholar 

  21. Reynolds C, Mick R, Donohue JH, et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 1999. 17:1720–1726

    PubMed  CAS  Google Scholar 

  22. Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer J Clin Oncol 2002. 20:3628–3636

    Article  PubMed  Google Scholar 

  23. Eroglu A, Mudun A, Ozmen V, et al. Comparison of subdermal and peritumoral injection techniques of lymphoscintigraphy to determine the sentinel lymph node in breast cancer. Clin Nucl Med 2004. 29:306–11

    Article  PubMed  CAS  Google Scholar 

  24. Fournier K, Schiller A, Perry RR, Laronga C, Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection Ann Surg 2004. 239:859–865

    Article  PubMed  Google Scholar 

  25. Dabbs DJ, Fung M, Landsittel D, McManus K, Johnson R, Sentinel lymph node micrometastasis as a predictor of axillary tumor burden Breast J 2004. 10:101–105

    Article  PubMed  Google Scholar 

  26. Mignotte H, Treilleux I, Faure C, Nessah K, Bremond A, Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients Eur J Surg Oncol 2002. 28:623–626

    Article  PubMed  CAS  Google Scholar 

  27. Bader AA, Tio J, Petru E, et al. T1 breast cancer: identification of patients at low risk of axillary lymph node metastases Breast Cancer Res Treat 2002. 76:11–17

    Article  PubMed  CAS  Google Scholar 

  28. Nos C, Harding-MacKean C, Fréneaux P, et al. Prediction of tumor involvement in remaining axillary lymph nodes when the sentinel node in a women with breast cancer contains metastases Br J Surg 2003. 90:1354–1360

    Article  PubMed  CAS  Google Scholar 

  29. Silverstein M, Skinner KA, Lomis TJ, Predicting axillary nodal positivity in 2282 patients with breast carcinoma World J Surg 2001. 25:767–72

    Article  PubMed  CAS  Google Scholar 

  30. Barth A, Craig P, Silverstein MJ, Predictors of axillary lymph node metastases in patients with T1 breast carcinoma Cancer 1997. 79:1918–22

    Article  PubMed  CAS  Google Scholar 

  31. Gajdos C, Tartter PI, Bleiweiss IJ, Lymphatic invasion, tumor size and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers Ann Surg 1999. 220:692–696

    Article  Google Scholar 

  32. Andea AA, Bouwman D, Wallis T, Visscher DW, Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma Cancer 2004. 100:20–27

    Article  PubMed  Google Scholar 

  33. Moore KH, Thaler HT, Tan LK, Borgen PI, Cody III HS, Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biologic metastasis or procedural artifact? Cancer 2004. 100:929–934

    Article  PubMed  Google Scholar 

  34. Viale G, Zurrida S, Maiorano E, et al. Predicting the status of axillary sentinel lymph nodes in 4351 patients with invaive breast carcinoma treated in a single institution Cancer 2005. 103:492–500

    Article  PubMed  Google Scholar 

  35. Chu KU, Turner RR, Hansen NM, et al. Do all patients with sentinel node metastases from breast carcinoma need complete axillary node dissection? Ann Surg 1999 229:536–541

    Article  PubMed  CAS  Google Scholar 

  36. Turner RR, Chu KU, Qi K, et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node Cancer 2000. 89:574–581

    Article  PubMed  CAS  Google Scholar 

  37. Wong SL, Edwards MJ, Chao C, et al. Predicting the status of the nonsentinel axillary nodes: a multicenter study Arch Surg 2001. 136:563–568

    Article  PubMed  CAS  Google Scholar 

  38. Sachdev U, Murphy K, Derzie A, Jaffer S, Bleiweiss IJ, Brower S, Predictors of nonsentinel lymph node metastasis in breast cancer patients Am J Surg 2002. 183:213–217

    Article  PubMed  Google Scholar 

  39. Hwang RF, Krishnamurthy S, Hunt KK, et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer Ann Surg Oncol 2003. 10:248–254

    Article  PubMed  Google Scholar 

  40. Degnim AC, Griffith KA, Sabel MS, et al. Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients: a metaanalysis Cancer 2003. 98:2307–2315

    Article  PubMed  Google Scholar 

  41. Joseph KA, El-Tamer M, Komenaka I, Troxel A, Ditkoff BA, Schnabel F, Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis Arch Surg 2004. 139:648–651

    Article  PubMed  Google Scholar 

  42. Saidi RF, Dudrick PS, Remine SG, Mittal VK, Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer Am Surg 2004. 70:101–105

    PubMed  Google Scholar 

  43. Viale G, Maiorano E, Mazzarol G, et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma Cancer 2001. 92:1378–1384

    Article  PubMed  CAS  Google Scholar 

  44. Abdessalam SF, Zervos EE, Prasad M, et al. Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer Am J Surg 2001. 182:316–320

    Article  PubMed  CAS  Google Scholar 

  45. Rahusen FD, Torrenga H, van Diest PJ, et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer Arch Surg 2001. 136:1059–1063

    Article  PubMed  CAS  Google Scholar 

  46. Changsri C, Prakash S, Sandweiss L, Bose S, Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery Breast J 2004. 10:392–397

    Article  PubMed  Google Scholar 

  47. Goyal A, Douglas-Jones A, Newcombe RG, et al. Predictors of non-sentinel lymph node metastasis in breast cancer patients Eur J Cancer 2004. 40:1731–1737

    Article  PubMed  CAS  Google Scholar 

  48. Viale G, Maiorano E, Prurevi G, et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy Ann Surg 2005. 241:319–325

    Article  PubMed  Google Scholar 

  49. Kamath VJ, Giuliano R, Dauway EL, et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection Arch Surg 2001. 136:688–692

    Article  PubMed  CAS  Google Scholar 

  50. Stitzenberg KB, Meyer AA, Stern SL, et al. Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden Ann Surg 2003. 237:607–612

    Article  PubMed  Google Scholar 

  51. Weiser MR, Montgomery LL, Tan LK, et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes Ann Surg Oncol 2001. 8:145–149

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, Istanbul Medical School, Istanbul University, Istanbul, Turkey

    V. Ozmen, H. Karanlik, A. Igci, M. Kecer & O. Asoglu

  2. Department of General Surgery, Haseki Research Hospital, Istanbul, Turkey

    N. Cabioglu

  3. Department of Pathology, Istanbul Medical School, Istanbul University, Istanbul, Turkey

    S. Tuzlali

  4. Department of Nuclear Medicine, Istanbul Medical School, Istanbul University, Istanbul, Turkey

    A. Mudun

Authors
  1. V. Ozmen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Karanlik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Cabioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Igci
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Kecer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. O. Asoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S. Tuzlali
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. Mudun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. Ozmen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ozmen, V., Karanlik, H., Cabioglu, N. et al. Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer. Breast Cancer Res Treat 95, 1–6 (2006). https://doi.org/10.1007/s10549-005-9007-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-005-9007-9

Keywords

Search

Navigation